T 1721/07 (CSF-1 Inhibitoren/HOFBAUER UND AHARINEJAD) of 29.03.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T172107.20120329
- Date of decision
- 29 March 2012
- Case number
- T 1721/07
- Petition for review of
- -
- Application number
- 00972422.0
- IPC class
- A61P 35/00A61K 39/395A61K 48/00
- Language of proceedings
- German
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in German
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Verwendung von CSF-1-Inhibitoren
- Applicant name
- Hofbauer, Reinhold
Aharinejad, Seyedhossein - Opponent name
- Novartis Vaccines and Diagnostics, Inc.
Amgen Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 84European Patent Convention R 124Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(2)Rules of procedure of the Boards of Appeal Art 6(4)
- Keywords
- Hauptantrag und Hilfsanträge 2 bis 4: Zulassung in Verfahren (nein)
Hilfsantrag 1: Klarheit (nein)
Berichtigung des Protokolls (nein) - Catchword
- -
ENTSCHEIDUNGSFORMEL
Aus diesen Gründen wird entschieden:
Die Beschwerde wird zurückgewiesen.